Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-Independent Prostatic Cancer”

156 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 156 results

Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Study completedNCT00350051
What this trial is testing

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

Who this might be right for
Prostate Cancer
Bayer 53
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Early research (Phase 1)Study completedNCT00052000
What this trial is testing

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00480090
What this trial is testing

A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 10
Testing effectiveness (Phase 2)Study completedNCT00274287
What this trial is testing

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 15
Testing effectiveness (Phase 2)Study completedNCT00121238
What this trial is testing

Cilengitide in Treating Patients With Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00174863
What this trial is testing

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sanofi 232
Testing effectiveness (Phase 2)Study completedNCT00182741
What this trial is testing

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 19
Testing effectiveness (Phase 2)Ended earlyNCT00471718
What this trial is testing

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Vanderbilt-Ingram Cancer Center 27
Large-scale testing (Phase 3)UnknownNCT00043576
What this trial is testing

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Who this might be right for
Prostate Cancer
Novacea 250
Not applicableStudy completedNCT00499694
What this trial is testing

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 31
Large-scale testing (Phase 3)Study completedNCT00436839
What this trial is testing

Taxotere Prostate Cancer New Indication Registration Trial in China

Who this might be right for
Prostatic Neoplasms
Sanofi 228
Early research (Phase 1)UnknownNCT00441571
What this trial is testing

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Cytogen Corporation 30
Testing effectiveness (Phase 2)Study completedNCT00260611
What this trial is testing

Study of Oxaliplatin and Taxotere in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Pittsburgh 34
Testing effectiveness (Phase 2)Study completedNCT00072930
What this trial is testing

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
MedImmune LLC 150
Testing effectiveness (Phase 2)Looking for participantsNCT07258407
What this trial is testing

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostatic Cancer
T.O.A.D. Oncology SA 180
Testing effectiveness (Phase 2)Study completedNCT00849290
What this trial is testing

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Who this might be right for
Metastatic Androgen Independent Prostate Cancer
Dendreon 113
Testing effectiveness (Phase 2)Study completedNCT00080678
What this trial is testing

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00258284
What this trial is testing

Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 30
Load More Results